Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.
Press releases published on September 23, 2025
September 23, 2025
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Indeterminate
GlobeNewswire
September 23, 2025
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
Indeterminate
GlobeNewswire
September 23, 2025
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
Indeterminate
GlobeNewswire
September 23, 2025
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
Indeterminate
GlobeNewswire
September 23, 2025
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Indeterminate
GlobeNewswire
September 23, 2025
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient
Indeterminate
GlobeNewswire
September 23, 2025
Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
Indeterminate
GlobeNewswire
September 23, 2025
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
Indeterminate
GlobeNewswire
September 23, 2025
Cytokinetics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
Indeterminate
GlobeNewswire
September 23, 2025
NYAM and Yale Center on Climate Change and Health Partner to Address Sustainable Health Systems
Indeterminate
GlobeNewswire
September 23, 2025
UPDATE - Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support
Indeterminate
GlobeNewswire
September 23, 2025
Dunham House Opens Applications for Residents
Indeterminate
GlobeNewswire
September 23, 2025
Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”) Announces Signing of a Securities Purchase Agreement with an Institutional Investor for the Purchase of $100 Million of shares of Se…
Indeterminate
GlobeNewswire
September 23, 2025
Branded Legacy Inc. Unveils Cutting-Edge GMP Facility to Accelerate Life-Saving Inhaled Naloxone Development
Indeterminate
GlobeNewswire